Eric Ostertag
2020
In 2020, Eric Ostertag earned a total compensation of $858.7K as Executive Chairman and former Chief Executive Officer at Poseida Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $301,460 |
|---|---|
| Salary | $548,115 |
| Other | $9,102 |
| Total | $858,677 |
Ostertag received $548.1K in salary, accounting for 64% of the total pay in 2020.
Ostertag also received $301.5K in non-equity incentive plan and $9.1K in other compensation.
Rankings
In 2020, Eric Ostertag's compensation ranked 9,221st out of 13,090 executives tracked by ExecPay. In other words, Ostertag earned more than 29.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,221 out of 13,090 | 30th |
Division Manufacturing | 3,941 out of 5,620 | 30th |
Major group Chemicals And Allied Products | 1,602 out of 2,253 | 29th |
Industry group Drugs | 1,401 out of 1,953 | 28th |
Industry Biological Products, Except Diagnostic Substances | 329 out of 411 | 20th |
Source: SEC filing on April 27, 2022.
Ostertag's colleagues
We found two more compensation records of executives who worked with Eric Ostertag at Poseida Therapeutics in 2020.